Harvard Pulmonary and Critical Care Medicine 2024

$65.00
$65.00
$0
Sold out
Quantity must be 1 or more

Harvard Pulmonary and Critical Care Medicine 2024

Full Videos + PDF Syllabus

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2024 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

  • Sepsis

  • ARDS

  • Sarcoidosis

  • IPF

  • Bronchiectasis

  • Cystic fibrosis

  • Lung nodules

  • Lung cancer

  • GERD

  • Pleural disease

  • Pneumonia

  • Tuberculosis
  • Thromboembolism

  • Chronic cough
  • COPD

  • Asthma
  • Occupational and environmental lung disease
  • Interstitial lung disease

  • Lung transplantation

  • Neurologic issues in the ICU

  • Sleep-disordered breathing

  • Post-acute sequelae of COVID-19

  • Surgical emergencies

  • Atypical mycobacterial disease

  • Pulmonary hypertension

  • Cardiopulmonary disorders

  • Complications from cardiac arrest

  • Hypersensitivity pneumonitis

  • Acute respiratory failure

REASONS TO ATTEND IN 2024

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

  • The most current guidelines for treating sepsis
  • Evidence-based treatment of ARDS
  • State of the art in interventional pulmonology
  • High-flow oxygen therapy for respiratory failure
  • Updates on biologics in asthma and other lung disease
  • New concepts in the use of vasopressors in septic shock
  • New drugs and combinations in pulmonary hypertension
  • New evidence on sedation, analgesia, and early mobility
  • Point-of-care pulmonary ultrasound in the intensive care unit
  • Lung microbiome: emerging implications for lung health
  • Emerging evidence for targeted temperature management
  • Evaluating occupational and environmental lung disease
  • Steroid-sparing agents for interstitial lung disease
  • Pulmonary embolus: the latest treatment strategies
  • State-of-the-art management of the critically ill patient
  • Guidance to conduct end-of-life discussions
  • Updates in pulmonary pathology
  • New treatment options in cystic fibrosis
  • Handling neurologic and surgical emergencies in the medical ICU
  • New approaches that improve outcomes for patients with unexplained chronic cough

Topics And Speakers:

Sunday, April 28, 2024

Morning Program
7:45am to 8:00am
Welcome

David J. Kanarek, MD

8:00am to 8:40am
GERD in Pulmonology

David J. Kanarek, MD

8:40am to 9:20am
Lung Transplantation 2024: Referral, Patient Selection, Lung Allocation, and COVID

Brian Keller, MD

9:20am to 10:00am
New Approaches to the Unexplained Chronic Cough

Kai Saukkonen, MD

10:00am to 10:10am
Break
10:10am to 10:50am
Occupational and Environmental Lung Disease

David Christiani, MD

10:50am to 11:30am
Cystic Fibrosis: Understanding CFTR and New Treatment

Isabel Neuringer, MD

11:30am to 12:10pm
Beyond Cystic Fibrosis: Diagnosis and Management of Non-CF Bronchiectasis

Christopher Richards, MD

12:10pm to 1:10pm
Q & A Session with Speakers

Drs. Christiani, Kanarek, Keller, Lai, Neuringer, Richards, Saukkonen, and Angela Frank, MD, MPH

1:10pm to 2:00pm
Break
Afternoon Program
2:00pm to 2:40pm
Pulmonary Pathology: Interstitial Lung Disease

Lida Hariri, MD, PhD

2:40pm to 3:20pm
Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs

Sydney Montesi, MD

3:20pm to 4:00pm
Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD

Barry Shea, MD

4:00pm to 4:10pm
Break
4:10pm to 4:50pm
Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!

Rachel Knipe, MD

4:50pm to 5:30pm
Treatment Challenges of Pulmonary Sarcoidosis

Robert Hallowell, MD

5:30pm to 6:10pm
Palliative Care in Advanced Lung Disease

Bethany-Rose Daubman, MD

6:10pm to 7:10pm
Q & A Session with Speakers

Drs. Daubman, Frank, Hallowell, Hariri, Knipe, Montesi, Shea, and Kathryn Hibbert, MD

Monday, April 29, 2024

Morning Program
8:00am to 8:40am
ARDS: State-of-the-Art Strategies to Protect the Lung

Kathryn Hibbert, MD

8:40am to 9:20am
Noninvasive Respiratory Support for Acute Respiratory Failure: Less May Not Be Best

Carolyn La Vita, MHA, RRT

9:20am to 10:00am
Novel Ventilator Modes: The Hype and Reality

Carolyn La Vita, MHA, RRT

10:00am to 10:10am
Break
10:10am to 10:50am
Fluid Responsiveness

David Ziehr, MD

10:50am to 11:30am
Vasopressors in Septic Shock: Old Friends and New

Jason Griffith, MD, PhD

11:30am to 12:10pm
Point-of-Care Pulmonary Ultrasound in the Intensive Care Unit

Jonah Rubin, MD

12:10pm to 1:10pm
Q & A with Speakers

Drs. Kanarek, North, Rubin, and Wong, and Carolyn La Vita, MHA, RRT

1:10pm to 2:00pm
Break
Afternoon Program
2:00pm to 2:40pm
The Legacy of COVID: A Clinical Approach to Post Acute Sequelae of COVID

Leo Ginns, MD

2:40pm to 3:20pm
After the ICU: Post-ICU Care Syndrome and Recovery

George Alba, MD

3:20pm to 4:00pm
Approach to Empiric Antibiotics in the ICU

Alyssa Letourneau, MD

4:00pm to 4:10pm
Break
4:10pm to 4:50pm
Approach to the Immunocompromised Critically Ill Patient

Lisa Bebell, MD

4:50pm to 5:30pm
Community-Acquired Pneumonia: The Newest Guidelines and State-of-the-Art Treatment Strategies State-of the-Art Treatment Strategies

Joshua Metlay, MD, PhD

5:30pm to 6:10pm
The Microbiome and Lung Disease

Peggy Lai, MD

6:10pm to 7:10pm
Expanded Q & A Session

Drs. Alba, Bebell, Ginns, Hibbert, Lai, Letourneau, and Metlay

Tuesday, April 30, 2024

Morning Program
8:00am to 8:40am
Common Neurologic Issues in the ICU

Sahar Zafar, MD

8:40am to 9:20am
From Ancient Egypt to Balanced Crystalloids: Medicine’s Attempts to Manage Sepsis

Eric Schmidt, MD

9:20am to 10:00am
Sedation, Analgesia and Early Mobility: The State of the Art in 2024

Crystal North, MD, MPH

10:00am to 10:10am
Break
10:10am to 10:50am
TTM and Neuroprognostication after Cardiac Arrest

David Greer, MD

10:50am to 11:30am
Prognosis and Uncertainty in the ICU

Emily Rubin, MD

11:30am to 12:10pm
Surgical Emergencies in the Medical ICU

Noelle Saillant, MD

12:10pm to 1:10pm
Q & A with Speakers

Drs. Frank, Greer, North, Rubin, Saillant, Schmidt, and Zafar

1:10pm to 2:00pm
Break
Afternoon Program
2:00pm to 2:40pm
Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2024?

Rachel Rosovsky, MD, MPH

2:40pm to 3:20pm
Pulmonary Embolism: An Update

Alison Witkin, MD

3:20pm to 4:00pm
Pulmonary Hypertension: Categorization and Evaluation

Josanna Rodriguez-Lopez, MD

4:00pm to 4:10pm
Break
4:10pm to 4:50pm
Pulmonary Hypertension: Management

Alexandra “Sasha” Wong, MD

4:50pm to 5:30pm
Vasculitis and ANCA

John Niles, MD

5:30pm to 6:10pm
Exercise and Cardiopulmonary Disorders: Indications and Interpretation

C. Corey Hardin, MD, PhD

6:10pm to 7:10pm
Q & A with Speakers

Drs. Hardin, Hibbert, Niles, Rodriguez-Lopez, Rosovsky, Witkin, and Wong

Wednesday, May 1, 2024

Morning Program
8:00am to 8:40am
Pleural Disease: 2024 Updates

Fayez Kheir, MD, MSc

8:40am to 9:20am
Interventional Pulmonology in 2024

Erik Folch, MD

9:20am to 10:00am
Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond

Colleen Keyes, MD, MPH

10:00am to 11:00am
Extended Q & A with Interventional Pulmonary Faculty

Drs. Folch, Frank, Keyes, and Kheir

11:00am to 11:10am
Break
11:10am to 11:50am
Looking Deeper: Patterns and Insights from Chest Radiology

Amita Sharma, MBBS

11:50am to 12:30pm
A Strategic Approach to the Management of Pulmonary Nodules

Angela Frank, MD, MPH

12:30pm to 1:10pm
Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies

Jaime Schneider, MD, PhD

1:10pm to 2:00pm
Break
Afternoon Program
2:00pm to 2:40pm
COPD 2024

Walter O'Donnell, MD

2:40pm to 3:20pm
Asthma: Ensuring Your Treatment Approaches Are Current with the State of the Art

Jehan Alladina, MD

3:20pm to 4:00pm
New Therapeutics in Lung Disease: The Age of Immunotherapy

Benjamin Medoff, MD

4:00pm to 4:10pm
Break
4:10pm to 4:50pm
Aspergillus Lung Disease

Rod Rahimi, MD

4:50pm to 5:30pm
Tuberculosis in 2024

Maha Farhat, MD, MSc

5:30pm to 6:10pm
Non-Tuberculous Mycobacterial Disease: Navigating the Labyrinth

Rocío Hurtado, MD, DTM&H

6:10pm to 7:10pm
Q & A with Speakers

Drs. Alladina, Farhat, Frank, Hibbert, Hurtado, Medoff, Metlay, Montesi, O'Donnell, Schneider, and Sharma

Thursday, May 2, 2024

Morning Program: Sleep Medicine for Pulmonologists
8:00am to 9:00am
Obstructive Sleep Apnea

James Mojica, MD, FAASM

9:00am to 10:00am
Complex Sleep Apnea 2024

James Mojica, MD, FAASM

10:00am to 10:10am
Break
10:10am to 11:10am
Sleep Diagnostics

Katherine Dudley, MD

11:10am to 12:10pm
Noninvasive Ventilation

Katherine Dudley, MD

12:10pm to 12:25pm
Break
12:25pm to 1:10pm
Q & A Session

Drs. Dudley, Kanarek, and Mojica

Go to full site